Patients with kidney stones. Calculus of kidney and ureter
Conditions
Interventions
Intervention 1: Intervention group: The intervention group (n = 30) received a capsul containing of 2 grams Portulaca Oleracea hydro alcoholic extract and half a gram of brown sugar should be taken w
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Age 18-65 years Literate
Exclusion criteria
Exclusion criteria: Patients with diabetes Oral problems No use of angiotensin II inhibitors Patients with colds
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum Potassium level. Timepoint: At the start of the study and at the end of the study. Method of measurement: blood sample.;Serum Sodium level. Timepoint: At the start of the study and at the end of the study. Method of measurement: blood sample.;24-hour urine uric acid. Timepoint: At the start of the study and at the end of the study. Method of measurement: 24 h Urine collection.;24-hour urine citrate. Timepoint: At the start of the study and at the end of the study. Method of measurement: 24 h Urine collection.;Specific weight of urine. Timepoint: At the start of the study and at the end of the study. Method of measurement: Urine sample.;24 hour urine calcium. Timepoint: At the start of the study and at the end of the study. Method of measurement: 24 h Urine collection.;24-hour urine creatinine. Timepoint: At the start of the study and at the end of the study. Method of measurement: 24 h Urine collection.;24-hour urine Na. Timepoint: At the start of the study and at the end of the study. Method of measurement: 24 h Urine collection. | — |
Secondary
| Measure | Time frame |
|---|---|
| Thirst intensity. Timepoint: At the start of the study, at the end of the study. Method of measurement: using Visual Analogue Scale.;Serum triglycerid level. Timepoint: At the start of the study and at the end of the study. Method of measurement: blood sample.;Serum cholestrol level. Timepoint: At the start of the study and at the end of the study. Method of measurement: blood sample.;Serum HDL level. Timepoint: At the start of the study and at the end of the study. Method of measurement: blood sample.;Total antioxidant level. Timepoint: At the start of the study and at the end of the study. Method of measurement: blood sample.;ESR. Timepoint: At the start of the study and at the end of the study. Method of measurement: blood sample.;CRP. Timepoint: At the start of the study and at the end of the study. Method of measurement: blood sample.;Serum Uric acid level. Timepoint: At the start of the study and at the end of the study. Method of measurement: blood sample.;Serum Creatinine level. Timepoint: At the start of the study and at the end of the study. Method of measurement: blood sample.;Serum Urea level. Timepoint: At the start of the study and at the end of the study. Method of measurement: blood sample.;Serum calcium level. Timepoint: At the start of the study and at the end of the study. Method of measurement: blood sample.;Venous blood gas. Timepoint: At the start of the study and at the end of the study. Method of measurement: blood sample. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmirhesam Alirezaei
Shahid Beheshti University of Medical Sciences
Outcome results
None listed